Breyanzi (lisocabtagene maraleucel)

pCPA File Number: 21939
Negotiation Status:
Concluded with an LOI
Adult patients with relapsed or refractory (R/R) large B-cell lymphoma after two or more lines of systemic therapy, including diffuse large B-cell lymphoma (DLBCL) not otherwise specified, primary mediastinal large B-cell lymphoma (PMBCL), high grade B-cell lymphoma, and DLBCL arising from follicular lymphoma
Celgene Inc.
CADTH Project Number:
pCPA Engagement Letter Issued:
Negotiation Process Concluded: